viralytics in the media, page-9

Yes my trend is your friend comment was a bit rich , interestedtoo was correct (see above posts)
Im hoping the nervous nellys sold in the last few months,no one wanted to catch a falling knife,but now it has stuck and the price will trend up.
Maybe some more data to come for the roadshows?
Phase I results ? The new CEO?
To me,this stock has takeover target written all over it.
Volume is up ,200k today at average 28.5 cents.

The Speculator did write about this stock,and only this stock today ,here is some .

The first began successful treatment in January with multiple injections into tumours over an 18-week period to monitor immune related progression-free survival at six months. (I understand that if the first 15 or 20 recruits show positive results, it may be possible to accelerate development without being required to run Stage 11 trials on all 54 targeted patients.)

Final clinical study reports for the Phase 1 trials are being prepared. In a report due this month, however, Prof. Shafren added that “we can say generally the intravenous and intratumoral delivery of a single dose of CAVATAK in late stage cancer patients was well-tolerated”.

I will stay with my under-valued portfolio holding. Readers might note that of the company’s 4.35 million unlisted options, all are well out-of the money with more than half exercisable at 70c and most of the rest at prices between $3 and $4.

Food for thought

Directors own most of the options exercisable during the next three years. Why would they bother with the task of running a company if they didn’t share some hope of a recovery?

Executive chairman Paul Hopper has more than 20 years’ experience in the management and funding of biotechnology and health care public companies. He is a partner in the Los Angeles merchant Bank Cappello Capital.

Among his colleagues on the board is non-executive director Dr Leonard Post, a past director and consultant to Biovex Ltd, acquired last year by US giant Amgen Inc in a US$1 billion deal.

Good luck to all staff,investors and Cancer patients